article · Scientific Reports

Comparative pharmacoinformatic and quantum descriptor insights from BFM/GBTLI guidelines to phase I/II compounds for acute lymphoblastic leukemia (ALL)

Ian A. F. Bahia
Magdi E. A. Zaki
Umberto L. Fulco
João Firmino Rodrigues-Neto
Maria Karolaynne da Silva
Emad Rashad Sindi
Yewulsew Kebede Tiruneh
Edilson D. da Silva
Taha Y. Alqahtani
Jonas I. N. Oliveira

2026Open accessBahir Dar University

In plain language

No abstract is available for this record, so no summary has been generated.

Research topics

Acute Lymphoblastic Leukemia research
Cancer therapeutics and mechanisms
Chronic Myeloid Leukemia Treatments

Read the original research

This page summarises published work. The authoritative version sits with the publisher.

View on publisher site Record on OpenAlex

DOI: 10.1038/s41598-026-36374-9

Is something wrong with this record? Report it or request removal.

Discussion

Discuss this research

Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.

No discussion yet. Open the first thread.

New to MARATTO™? Create a free account.